The detection of non-tumor-derived clonal hematopoietic mutations (TP53, DNMT3A, etc.)has been reported as a source of the biological background noise of ctDNA detection that could lead to an inappropriate therapeutic decision. This evidence concerns the gene DNMT3A and neoplasm.